These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Recent advances in the treatment of myelodysplastic syndromes]. Gelsi-Boyer V; Vey N Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation. Lindsley RC; Saber W; Mar BG; Redd R; Wang T; Haagenson MD; Grauman PV; Hu ZH; Spellman SR; Lee SJ; Verneris MR; Hsu K; Fleischhauer K; Cutler C; Antin JH; Neuberg D; Ebert BL N Engl J Med; 2017 Feb; 376(6):536-547. PubMed ID: 28177873 [TBL] [Abstract][Full Text] [Related]
18. Mutations of myelodysplastic syndromes (MDS): An update. Ganguly BB; Kadam NN Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316 [TBL] [Abstract][Full Text] [Related]
19. [Familial incidence of myelodysplastic syndromes]. Wróbel T; Mazur G; Pyszel A; Biedroń M; Kuliczkowski K Wiad Lek; 2006; 59(3-4):285-8. PubMed ID: 16813282 [TBL] [Abstract][Full Text] [Related]
20. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review]. Zhang Z; Li X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]